Mustang Bio (MBIO) Net Cash Flow (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Net Cash Flow of -$1.0 million for Q1 2026, down 113.64% year-over-year from $7.4 million in Q1 2025, and up 41.33% quarter-over-quarter from -$1.7 million in Q4 2025.
Mustang Bio (MBIO) Net Cash Flow (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Net Cash Flow for 11 consecutive years, with -$1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 113.64% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 83.81% YoY), while the FY2025 annual figure was $10.4 million, up 7291.03% from the prior year.
- Net Cash Flow advanced to -$1.0 million in Q1 2026 per MBIO's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $12.6 million in Q1 2022 and bottomed at -$42.7 million in Q2 2023.
- Historically, Net Cash Flow has averaged -$5.6 million across 5 years, with a median of -$1.7 million in 2025.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 2789.67% — and 2025, when it surged 951.55%.
- Mustang Bio's Net Cash Flow stood at -$15.7 million in 2022, then soared by 78.81% to -$3.3 million in 2023, then jumped by 188.31% to $2.9 million in 2024, then slumped by 158.46% to -$1.7 million in 2025, then soared by 41.33% to -$1.0 million in 2026.
- Business Quant data shows MBIO's Net Cash Flow at -$1.0 million in Q1 2026, -$1.7 million in Q4 2025, and $6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 225.59 Mn |
| 10 | Mustang Bio | 3.86 Mn | 3.86 Mn | - | -1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11 Mn |
| Jun 30, 2026 | -1.11 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | -1.72 Mn |
| Dec 31, 2025 | -1.72 Mn |
| Sep 30, 2025 | 6.33 Mn |
| Sep 30, 2025 | 6.33 Mn |
| Jun 30, 2025 | -1.57 Mn |
| Jun 30, 2025 | -1.57 Mn |
| Mar 31, 2025 | 7.39 Mn |
| Mar 31, 2025 | 7.39 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Sep 30, 2024 | -743,000.00 |
| Sep 30, 2024 | -743,000.00 |
| Jun 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | -5.27 Mn |
| Mar 31, 2024 | -5.27 Mn |